Company news

On the afternoon of December 21, Xiamen Wiz Biotech Co., Ltd. and Xiamen Zhuqiang Large Pharmacy Co., Ltd. had an in-depth discussion on how to meet citizens' demand for novel coronavirus antigen test kits, reached and established a strategic partnership, to assist Xiamen in epidemic prevention and control.

On December 21, Xiamen Wiz Biotech Co., Ltd and Xiamen Luyan Pharmacy Co., Ltd signed a strategic cooperation on COVID-19 antigen test kit. Su Jinkun (Mr.), General manager of Xiamen Luyan Pharmacy, Lin Lin (Ms.), Deputy general manager of Retail Division of Luyan Group, and Wang Xiaozhen (Ms.), general manager of Wiz Biotech, Sales Director Peng Que'en (Mr.) attended the ceremony.

Xiamen Weizheng Biotechnology Co., LTD has been awarded the Export Commodity Brand Certificate issued by the China Council for the Promotion of International Trade. The success of this certificate for the company to build international brand image, enhance the company's international brand influence and competitiveness in the international market, help the company to efficiently develop overseas markets.

In order to provide our customers with better service and create a better office environment for our employees, Wiz moved to a new office area on August 28, 2022.

In the workshop of Xiamen Wiz Biotech Co., Ltd, workers dressed in neat overalls sit in front of the operating table and methodically pack test reagents for COVID-19 antigen.

As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.

iamen Wiz Biotech Co., Ltd is located in Xiamen Biopharmaceutical Port. The company takes rapid diagnosis as its entry point and focuses on gastrointestinal and digestive fields. From research and development, registration and approval, to market access, sales network......

COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,

Our company's "Novel Coronavirus Antibody Screening and Shunt Prevention and Control rapid detection system" has been approved by Xiamen Science and Technology Bureau.

Xiamen Wiz Biotech Co., Ltd. was listed and traded on the New Third Board on February 5, 2017. The stock name is Wiz Biotech (stock code 839355).